Levetiracetam Neuraxpharm (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A, which modulates neurotransmitter release. This action stabilizes neuronal firing and reduces hyper‑excitability, helping to prevent the spread of seizure activity in the central nervous system.

The dosing regimen for Levetiracetam Neuraxpharm is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, age, renal function, and response to therapy.

The safety of levetiracetam in pregnancy and lactation has not been fully established. Prescribers should weigh potential benefits against possible risks and consider alternative therapies when appropriate.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam has a unique mechanism targeting SV2A, which differs from many other antiepileptics that act on ion channels or GABA receptors. It is generally well tolerated, has few drug‑enzyme interactions, and is often chosen when patients need a medication with a low interaction profile.

Levetiracetam Neuraxpharm should be stored at ambient temperature, protected from light and moisture, and kept in its original packaging until ready for use.

The product is supplied as an intravenous solution and is administered by slow infusion into a vein under the supervision of a healthcare professional, following the prescriber’s instructions.

Serious risks include severe allergic reactions such as anaphylaxis, rare skin conditions like Stevens‑Johnson syndrome, blood dyscrasias, and the emergence of suicidal thoughts or behaviors. Patients should be monitored closely for these events.

Patients with known hypersensitivity to levetiracetam or any component of the formulation should avoid use. Caution is also advised for individuals with severe renal impairment or uncontrolled psychiatric conditions, and the drug should be prescribed only after a thorough clinical assessment.